Esketamine combined with hydromorphone versus hydromorphone for post-operative patient-controlled intravenous analgesia in children: a randomized controlled trial.

BACKGROUND: Postoperative pain and opioid-related adverse effects remain significant concerns in pediatric surgical patients. Esketamine, an NMDA receptor antagonist, may enhance analgesia and reduce opioid consumption at low doses. This study aimed…

Preview only. Read the full abstract at the source